Rare DiseasesSerebrotendinous Xanthomatosis: Causes, Symptoms, Diagnosis, Treatment, and Management

Serebrotendinous Xanthomatosis: Causes, Symptoms, Diagnosis, Treatment, and Management

Serebrotendinous xanthomatosis (CTX) is an autosomal recessive genetic disease where the enzyme sterol 27-hydroxylase, which regulates and processes cholesterol in the body, is dysfunctional or deficient. The impairment of this enzyme’s function leads to the inability to process cholesterol normally, resulting in its accumulation. Genetic testing can be conducted to diagnose CTX. Treatment may focus on managing the symptoms of CTX, particularly addressing cholesterol buildup and neurological issues. Sometimes, cholesterol-lowering medications are used, and rehabilitation or medication may be required to manage neurological symptoms.

Causes of Serebrotendinous Xanthomatosis

Serebrotendinous xanthomatosis is a genetic disorder, and its underlying cause is a genetic mutation:

Genetic Mutation: CTX is an autosomal recessive genetic disorder where the enzyme sterol 27-hydroxylase is dysfunctional or deficient.

Inheritance: CTX follows a recessive inheritance pattern, meaning both parents must carry the mutation to pass on the disease.

Symptoms of Serebrotendinous Xanthomatosis

The symptoms of serebrotendinous xanthomatosis can vary depending on the patient’s age, the severity of the disease, and the response to treatment:

  • nervous system symptoms
  • eye problems
  • skeletal abnormalities
  • liver problems
  • cardiovascular issues
  • digestive problems

Diagnosis of Serebrotendinous Xanthomatosis

The diagnosis of serebrotendinous xanthomatosis is made through the evaluation of symptoms and clinical findings, genetic testing, and sometimes laboratory investigations:

Medical History and Physical Examination: The doctor will thoroughly examine the patient’s medical history and symptoms.

Genetic Testing: The most reliable method for diagnosing CTX is conducting genetic tests to detect mutations in the CYP27A1 gene.

Blood Tests: Blood tests can be used to assess cholesterol levels, specific components like 27-hydroxycholesterols, and liver function.

Eye Examination: Eye examinations may be performed as vision problems are common in CTX patients.

Imaging Tests: Brain imaging tests can be used to evaluate changes in the central nervous system.

Biopsy: Rarely, a biopsy using skin or other tissue samples can support the diagnosis of CTX.

Treatment of Serebrotendinous Xanthomatosis

The treatment of serebrotendinous xanthomatosis may involve various methods to alleviate symptoms, reduce cholesterol buildup, and prevent disease progression:

Cholesterol-Lowering Medications: Cholesterol-lowering medications can be used to lower cholesterol levels and reduce accumulation.

Cholecalciferol Supplements: CTX patients may be advised to take cholecalciferol supplements to support bone health and reduce the risk of osteomalacia or osteoporosis.

Medication: Certain medications may be used to manage neurological symptoms.

Treatment of Eye Problems: Treatment methods for eye problems related to CTX are directed by an ophthalmologist.

Regular Monitoring and Follow-up: It is important for CTX patients to be regularly monitored by a specialist and for their symptoms to be tracked.

Management of Serebrotendinous Xanthomatosis

The management of serebrotendinous xanthomatosis includes a range of measures to alleviate symptoms, prevent complications, and improve quality of life:

Medication: Cholesterol-lowering medications are used in the treatment of CTX.

Supporting Bone Health: Due to the potential negative impact of CTX on bones, vitamin D3 supplements and calcium supplements may be recommended.

Management of Neurological Symptoms: Medications can be used to manage CTX patients’ neurological symptoms.

Specialized Eye Monitoring: Regular eye examinations and specific measures for eye health are important.

Diet and Exercise: Maintaining a healthy diet and engaging in regular exercise can help improve overall health and keep cholesterol levels under control.

Psychosocial Support: CTX patients should receive psychosocial support.

Regular Follow-up: CTX patients should be regularly monitored by a healthcare professional.

.

Exclusive content

Latest article

More article